Retinoic acid receptor alpha (RARA) and retinoid X receptor alpha (RXRA), which negatively correlate with POLR3G expression across cancers, are retinoid-activated nuclear receptors that mediate transcriptional programs by forming homo- and heterodimers in the presence or absence of specific ligands [39]. The gene discussed is RARA; the disease is cancer.